Skip to main content

Completed

Supply Chain Acceleration and Logistics Enablement (SCALE) Program

Limit: 1 // Tickets Available: 0 

Y. Wang (Systems and Industrial Engineering)

Limiting Language
An Applicant may submit only one proposal in response to this Announcement. Any additional applications from the same organization will automatically be rejected without being evaluated. 

Purpose
The SCALE Program supports organizations that help small businesses overcome operational, technical, workforce, and market access barriers that limit their ability to participate and grow as suppliers within strategically important industries.

Through technical assistance, industry engagement, and other implementation focused activities, SCALE helps small businesses address identified supply chain constraints, strengthen supplier readiness, improve production capability, and expand participation in strategically important supply chains.

Through this program, SBA seeks to:

• Accelerate Small Business Supplier Development: Improve the readiness, production capability, market access, and growth of small businesses participating in strategically important supply chains.

• Address Supply Chain Constraints: Support efforts that address demonstrated supply chain bottlenecks, vulnerabilities, supplier gaps, and barriers to supplier participation and growth.

• Expand Small Business Participation: Expand participation of small businesses within strategically important supply chains.

• Deliver Measurable Results: Generate measurable improvements in small business supplier readiness, supply chain participation, and small business growth.

• Improve Industrial Coordination: Strengthen coordination among industry, workforce, technical assistance, and other partners supporting supplier growth and supply chain participation.

Funding Type
External Deadline
8/7/2026

Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional)

No Applicants // Limit: 1 // Tickets Available: 1 

Limiting Language
Only one application per institution (normally identified by having a unique UEI number or NIH IPF number) is allowed.

Purpose
In response to a longstanding congressional mandate (P.L. 98-619, Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriation Act, 1985), NIMHD invites applications from eligible institutions to establish a national coordinating center (CC) for the Research Centers in Minority Institutions (RCMIs) initiative. The RCMI CC will coordinate activities across funded RCMI U54 Centers, prospectively evaluate the overall RCMI program, and serve as a national resource to help these centers achieve their primary goals. The RCMI CC will be responsive to requests generated by RCMI site key personnel, NIMHD, NIH, the scientific community, and the general public. 
 

Funding Type
External Deadline
8/7/2026

Freedom 250 Great American State Fair Initiative – Abu Dhabi

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language 
Applicants are only allowed to submit one proposal per organization. If more than one proposal is submitted from an organization, all proposals from that institution will be considered ineligible for funding under this funding opportunity.

Executive Summary 
The U.S. Embassy Abu Dhabi, Public Diplomacy Section, announces an open competition to develop and implement the programmatic elements of a three-day Freedom 250 Great American State Fair. The Fair will showcase authentic American heartland culture, creativity, entrepreneurship, entertainment, culinary traditions, and music through immersive public programming designed for UAE audiences. 

Proposals should showcase American excellence, advance American commercial interests, enhance American brand visibility through public engagement, American vendor participation, strategic partnerships, and cultural programming, and strengthen the U.S.-UAE bilateral relationship. 

If selected, the grantee would deliver a comprehensive American State Fair with multiple touchpoints, including but not limited to interactive gaming attractions, themed parades, entertainment showcases, curated exhibitions, family-centric experiences, and an expansive culinary and retail village concept featuring American food brands and artisan vendors, all of which will collectively create an immersive and authentic American state fair experience. 

The selected grantee will be responsible for the design, curation, and implementation of the Freedom 250 Great American State Fair programming and participant experience. The grantee will be expected to coordinate closely with our UAE Local Partner Entity and their contractors, which will provide venue infrastructure and operational support. (Those services are subject to grantee negotiation with the UAE Local Entity and PDS involvement and may include but are not limited to the following: venue construction and dismantling, staging and physical infrastructure, ticketing operations, site setup and cleanup, utilities, waste management, security plans and coordination, public facilities, and other event logistics.) Accordingly, applicants for this Notice of Funding Opportunity should focus their proposals on programming, participant engagement, U.S. vendor recruitment and management, American cultural and commercial activations, and overall authentic event experience rather than venue operations and infrastructure. A detailed division of responsibilities will be provided to successful applicants and may be further refined in coordination with the Public Diplomacy Section and the UAE Local Entity. 

This initiative directly supports U.S. foreign policy objectives and makes America stronger, safer, and more prosperous by advancing American commercial interests, showcasing U.S. excellence and innovation, positioning American businesses and cultural exports at the center of the UAE’s dynamic cultural and entertainment sector as it reemerges from the regional conflict, and strengthening strategic partnerships with the United Arab Emirates. 

As a Freedom 250 initiative, the Fair will celebrate 250 years of American independence and achievement and will showcase the unique culture and traditions of the American heartland. As a condition of award, the selected grantee will be required to sign a Memorandum of Understanding (MOU) with the UAE Local Entity, the co-host of the Freedom 250 Great American State Fair in Abu Dhabi, immediately after the award is signed with the U.S. Government (PDS UAE). 

The MOU will govern the operational, programmatic, and logistical responsibilities of the grantee in relation to the co-hosted event and will set forth the terms and conditions under which the grantee will collaborate with the UAE Local Entity. The grantee must conduct all activities in accordance with the terms and conditions established, as well as those set forth in the grant agreement with the U.S. Embassy Abu Dhabi's Public Diplomacy Section.

Research Category
Funding Type
External Deadline
8/10/2026

United States Mission to the United Kingdom

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language 
Applicants are only allowed to submit one proposal per organization. If more than one proposal is submitted from an organization, all proposals from that institution will be considered ineligible for funding under this funding opportunity.

Executive Summary
The U.S. Embassy to the United Kingdom of the U.S. Department of State is pleased to announce that funding is available through its Public Diplomacy Section program. This is an Annual Program Statement, outlining our funding priorities, the strategic themes we focus on, and the procedures for submitting requests for funding.
 

Research Category
Funding Type
External Deadline
8/10/2026

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) - PAR-23-286, PAR-23-287

Limit: 4* (see below) // Tickets Available: 2

Cancer Data Science // Limit: 1 // Tickets Available: 0
E. Ochoa Mora (Epidemiology and Biostatistics)

Cancer Control Science // Limit: 1 // Tickets Available: 0
J. Llavona-Ortiz (Cancer Center)

Molecular Precision/Cancer Prevention // Limit: 1 // Tickets Available: 1 

Other Cancer Research // Limit: 1 // Tickets Available: 1

Limiting Language
Each eligible institution (defined as having a unique UEI number or NIH IPF number) may submit up to a combined total of four applications (one in Cancer Data Science, one in Cancer Control Science, one in Molecular/Precision Cancer Prevention, and one in Other Cancer Research) to any companion NOFO or any combination of companion NOFOs (PAR-23-286, PAR-23-287, and/or PAR-23-288 (archived)).

Scientific Areas

  • (A) Cancer Data Science: For the purposes of this K99/R00 award, cancer data science is defined as an interdisciplinary field of inquiry in which quantitative and analytical approaches, processes, and systems are both developed and used to extract knowledge and insights from increasingly large and/or complex sets of data. This includes cancer-focused data integration and visualization, systems biology, artificial intelligence, machine learning, informatics, genomics, precision oncology, and developing analytics for epidemiological or biostatistical studies.
  • (B) Cancer Control Science: For the purposes of this K99/R00 award, cancer control science is defined as basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that, independently or in combination with biomedical approaches reduce cancer risk, incidence, morbidity, and mortality, and improve quality of life. This includes research in epidemiology, behavioral sciences, health services, surveillance, cancer survivorship, and healthcare policy.
  • (C) Molecular/Precision Cancer Prevention: For the purpose of this K99/R00 award, early translational research in cancer prevention is defined as basic research to understand mechanisms of cancer formation, development and progression of cancer precursors, and to translate basic biological knowledge into novel human interventions and human-centered adaption of current interventions with the potential to reduce cancer risk, incidence, and mortality, and improve quality of life. This includes but is not limited to research in molecular and systems biology, diagnostics, vaccine and drug development, pharmacology, and biomedical engineering.
  • (D) Other Cancer Research: For the purposes of this K99/R00 award, "Other Cancer Research" includes all scientific fields supported by the NCI that are not included in (A), (B) or (C). Applicants proposing research in (D) "Other Cancer Research" may apply only if it is reasonable to expect their candidates to transition to independence with an abbreviated period of mentored research training beyond their original doctoral degrees."
Funding Type
External Deadline
10/14/2026

Rita Allen Foundation Scholars Program

Limit: 1 // Tickets Available: 0 

S. Song (Biomedical Engineering)

Limiting Language
One nominated candidate per eligible institution is accepted per year

Program Overview
The Rita Allen Foundation Scholars program funds basic biomedical research in the fields of cancer, immunology, and neuroscience, as well as pain, through the Rita Allen Foundation Award in Pain. The Rita Allen Foundation Scholars program has supported more than 200 scientists since 1976. The program embraces innovative research with above-average risk and groundbreaking possibilities. Scholars have gone on to win the Nobel Prize in Physiology or Medicine, the National Medal of Science, the Wolf Prize in Medicine and the Breakthrough Prize in Life Sciences.

Full sponsor guidelines are linked here. 

Award Amount
Scholars can receive up to $110,000 per year for a maximum of five years. Recipients of the Award in Pain can be granted $50,000 per year for up to three years.

Eligibility
To be eligible for a Rita Allen Foundation Scholars Award, candidates must either apply through the Scholars Award in Pain or be nominated by an eligible institution and have completed their training and provided persuasive evidence of distinguished achievement or extraordinary promise in research in one of the relevant fields (cancer, immunology, neuroscience. or pain). United States citizenship is not a requirement; however, awardees must be legally employed at the time of application at a U.S. degree-granting or research institution that is an invited participant in the Rita Allen Foundation Scholars Program. Awards are made to the 501(c)(3) organization; awards are not made to an individual. Scholars must perform research at a non-profit institution in the U.S. during the entire period of Rita Allen Foundation support.

Institutions should consider the following when considering whom to nominate for the Rita Allen Foundation Scholars program: 

  • Candidates should be independent investigators in the early stages of their careers and research. 
  • The caliber of early-stage investigators suggests nominees would be appointed to tenure-track positions at their respective institutions. 
  • It is preferable that candidates be in the first three years of their tenure track. (This is taken into consideration in the rating of applications by the Scientific Advisory Committee.) 
  • A senior postdoc should not be a candidate; wait until s/he is in a tenure-track position, as described. 
  • Associate professors should not be candidates. 
  • Candidates must have received committed startup funds from their respective institutions. 
  • Candidates must have lab space from their institutions. 

Rita Allen Foundation Scholars may not accept an award from the Beckman Young Investigator Program, Pew Scholars Program in the Biomedical Sciences, Searle Scholars Program, or Vallee Scholars Program that would take effect beginning in year one of the RAF award. Rita Allen Scholars may apply for awards from these organizations that would take effect beginning in year two of the RAF award. Other sources of funding also may influence selection. 

Funding Type
External Deadline
9/3/2026 (LOI); 10/14/2026 (Application)
Internal Deadline
Internal Time
5:00PM
Solicitation Type

Medical Student Education Program (MSE)

No Applicants // Limit: 1 (COM-T) // Tickets Available: 1 

Limiting Language
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.


Purpose
The purpose of the Medical Student Education (MSE) Program is to provide support to public medical schools in states ranked in the top quartile for projected primary care provider shortages. to expand or enhance education for medical students preparing to become physicians. This expansion can include funding for direct student supports which help students be successful in medical school, as well as for infrastructure development, maintenance, equipment, and minor renovations or alterations. The program is designed to prepare and encourage medical students to choose residencies and careers in primary care and serve Tribal, rural and other areas with primary care provider shortages in those states after they complete their residency.

  • Increase the number of primary care physicians practicing in states with a projected primary care physician shortage, particularly in rural Tribal and other areas with primary care provider shortages.

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.

Purpose
This Notice of Funding Opportunity (NOFO) invites applications for a Research Coordinating Center (RCC) to participate in a consortium of clinical centers that will test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs. Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts

The RCC will lead, manage, and harmonize efforts for the Consortium including 1) providing management and administrative support; 2) providing leadership and expertise on statistical design and analysis, 3) providing research coordination with a central laboratory, 4) harmonizing data collection methods and use of common data elements, 5) developing the database; 6) conducting data management and data analyses for Consortium studies; and 7) fostering research collaborations. This NOFO uses a cooperative agreement mechanism (U24) and runs in parallel with a companion NOFO (RFA-DK-27-121).

Full sponsor guidelines are linked here. 
 

Funding Type
External Deadline
10/9/2026

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.


Purpose
This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs.  Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts. 

Full sponsor guidelines are linked here. 

Funding Type
External Deadline
10/9/2026

Rural Cooperative Development Grants

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language 
An eligible institution may not submit more than one application to this program as a lead institution. This includes applications from subordinate units under a parent institution. Additionally, eligible recipients may only receive funds for one award at a time. Prospective applicants are advised to contact their institutional sponsored projects office regarding processes used to select proposals for submission. For RFAP purposes, ‘parent institution’ refers to the single, legally distinct institution of higher education that oversees its colleges, schools, and departments. A separate UEI by itself does not automatically make a campus or unit a different institution. Some campuses, divisions, or administrative units within a university system may maintain their own UEIs for grants management purposes while still operating under the governance, accreditation, and legal identity of a single parent institution. In such cases, the parent institution, not the UEI, is the controlling factor in determining the one application limit. The one application limit applies to all subordinate units under the same institution. However, university systems with multiple independently accredited and governed institutions may submit one application per institution within the system. A multi campus university system may submit more than one application only if each campus is recognized as a distinct institution based on its own independent accreditation, governance structure, and institutional identity. Institutions that have received congressionally directed funding for research facility projects are not excluded from participation in this program. Such institutions may submit applications and compete for additional projects under this competitive funding opportunity. 

Cost Sharing Requirements
Applicants MUST provide at minimum a 1:1 matching contribution on a dollar-for-dollar basis for all Federal funds awarded under the RFAP. The non-Federal share must be paid in cash and may include funding from private sources or from units of State or local government. In-kind matching will not be considered. See 7 U.S.C. 390a(c)(2)(A). The full match amount must be budgeted in the application, with sources of funding clearly disclosed. Recipients may phase matching contributions, potentially synchronized with project construction milestones, or raise additional funds during the project period, provided that the Authorized Representative signs the award, thereby attesting to fulfill all match commitments. Matching costs must be incurred during the federal award period, align with 2 CFR 200.306 requirements (verifiable, allowable, not double counted, and included in the approved budget), and be properly documented and reported cumulatively via the SF425 Federal Financial Reports throughout and at the conclusion of the project Consistent with 48 U.S.C. 1469a, notwithstanding any other provision of law, in the case of American Samoa, Guam, the Virgin Islands, the Federated States of Micronesia, and the Northern Mariana Islands, NIFA will waive any requirement for local matching funds under $200,000 (including in-kind contributions). 

Executive Summary
This notice identifies the objectives for RCDG program projects, deadlines, funding information, eligibility criteria for projects and applicants, and application forms and associated instructions. NIFA requests applications for grants under the RCDG program for FY 2026 to improve the economic condition of rural areas by helping nonprofit organizations who in turn provide technical assistance to start, expand, or improve cooperatives and mutually owned businesses in rural areas. This notice is being issued to allow applicants sufficient time to leverage financing and prepare and submit their applications.  

Estimated funding amounts are not guaranteed and are subject to the availability of appropriated funds.